Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Stem Cell Factor-responsive FcepsilonRI Bearing Human Mast Cell Line LAD2
Case ID:
TAB-641
Web Published:
12/6/2022
A human mast cell line LAD2 that more closely resembles normal in vivo and in vitro human mast cells by expressing functional FcepsilonRI receptors and responding to stem cell factor (SCF) with proliferation, as described in Leuk Res. 2003 Aug;27(8):677-82 and developed by the laboratory of Dr. Dean Metcalfe at the National Institute of Allergy and Infectious Diseases. This cell line also releases mediators by cross-linking FcgammaRI (CD64) receptors and express FcgammaRII (CD32).
Patent Information:
Title
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Expire Date
Direct Link:
https://canberra-ip.technologypublisher.com/tech/Stem_Cell_Factor-responsive_ FcepsilonRI_Bearing_Human_Mast_Cell_Line_LAD2
Keywords:
Cell line
IA3XXX
IAXXXX
IDXXXX
IXXXXX
Mast cell disease
Mastocytosis
RM
WIXXXX
Bookmark this page
Download as PDF
For Information, Contact:
Daniel Lee
Senior Licensing and Patenting Manager
NIH Technology Transfer
daniel.lee5@nih.gov